Utilization of sialylated glycans as coreceptors enhances the neurovirulence of serotype 3 reovirus.
about
Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus VariantsDiminished reovirus capsid stability alters disease pathogenesis and littermate transmissionThe GM2 Glycan Serves as a Functional Coreceptor for Serotype 1 ReovirusReovirus-mediated induction of ADAR1 (p150) minimally alters RNA editing patterns in discrete brain regions.Endothelial JAM-A promotes reovirus viremia and bloodstream dissemination.Glycan engagement dictates hydrocephalus induction by serotype 1 reovirus.Tulane virus recognizes sialic acids as cellular receptors.Comparison of three neurotropic viruses reveals differences in viral dissemination to the central nervous systemThe sweet spot: defining virus-sialic acid interactions.Directional release of reovirus from the apical surface of polarized endothelial cellsEngineering recombinant reoviruses with tandem repeats and a tetravirus 2A-like element for exogenous polypeptide expressionEngineering Recombinant Reoviruses To Display gp41 Membrane-Proximal External-Region Epitopes from HIV-1Unique glycan signatures regulate adeno-associated virus tropism in the developing brain.Structure of Serotype 1 Reovirus Attachment Protein σ1 in Complex with Junctional Adhesion Molecule A Reveals a Conserved Serotype-Independent Binding Epitope.Viral gene expression potentiates reovirus-induced necrosis.The bulky and the sweet: How neutralizing antibodies and glycan receptors compete for virus binding.The Nogo receptor NgR1 mediates infection by mammalian reovirus.
P2860
Q26775033-AB40C231-9C9D-477F-8BF1-5813731E7741Q27321066-BC23B486-AB3E-4674-996B-BFAE678D59D5Q27675479-9DC0CD24-2855-43FA-A34E-F232D1CBDF69Q34053640-03088330-0345-4856-834A-5354D0957463Q35152799-3478B097-DBF8-49D3-ADF6-A0CC5440CF97Q35172332-ABD0BBCF-6803-4716-BDB3-70A233731284Q35819128-9122C5E3-1209-4C47-B415-AD832067D9D8Q36373033-474BCC2E-82A5-44A5-A75D-E7A66F92253AQ36685206-0E471AE7-35F2-443D-A94C-38BA7A1A033BQ36756605-90212F89-E697-4246-9670-4D227D3C0CD9Q36855368-F0EFD51E-AC20-48FE-87BB-EA0ADCFCDDE5Q36956100-E553EE05-BAA8-4DB3-A668-A51C33A92C31Q39795021-6148B1B6-4CB7-47A8-B598-F8C34D761D5AQ41014473-E5E99E65-CF94-4B3C-A673-D5E2F6EED20CQ41080969-B0CD3BF1-66CF-465E-A65B-54C972751EE9Q41922286-88433213-95D9-4FA3-A6EF-3BA565822320Q42210794-C0F0C327-3932-451F-BC92-61A8CEB7237A
P2860
Utilization of sialylated glycans as coreceptors enhances the neurovirulence of serotype 3 reovirus.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Utilization of sialylated glyc ...... ulence of serotype 3 reovirus.
@en
type
label
Utilization of sialylated glyc ...... ulence of serotype 3 reovirus.
@en
prefLabel
Utilization of sialylated glyc ...... ulence of serotype 3 reovirus.
@en
P2093
P2860
P356
P1433
P1476
Utilization of sialylated glyc ...... ulence of serotype 3 reovirus.
@en
P2093
Dirk M Reiter
Jennifer L Konopka
Johnna M Frierson
Terence S Dermody
Thilo Stehle
P2860
P304
13164-13173
P356
10.1128/JVI.01822-12
P407
P577
2012-10-03T00:00:00Z